These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17593069)

  • 1. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain.
    Nyrop KA; Palsson OS; Levy RL; Von Korff M; Feld AD; Turner MJ; Whitehead WE
    Aliment Pharmacol Ther; 2007 Jul; 26(2):237-48. PubMed ID: 17593069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual Costs of Care for Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, and Functional Abdominal Pain Syndrome.
    Hoekman DR; Rutten JM; Vlieger AM; Benninga MA; Dijkgraaf MG
    J Pediatr; 2015 Nov; 167(5):1103-8.e2. PubMed ID: 26329806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.
    van Tilburg MA; Palsson OS; Levy RL; Feld AD; Turner MJ; Drossman DA; Whitehead WE
    BMC Complement Altern Med; 2008 Jul; 8():46. PubMed ID: 18652682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    Buono JL; Mathur K; Averitt AJ; Andrae DA
    J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden attributable to functional bowel disorders in Iran: a cross-sectional population-based study.
    Moghimi-Dehkordi B; Vahedi M; Pourhoseingholi MA; Khoshkrood Mansoori B; Safaee A; Habibi M; Pourhoseingholi A; Zali MR
    J Dig Dis; 2011 Oct; 12(5):384-92. PubMed ID: 21955432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
    Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
    Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.
    Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT; Doshi JA
    J Med Econ; 2014 Feb; 17(2):148-58. PubMed ID: 24168640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial: transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study.
    Coban Ş; Akbal E; Köklü S; Köklü G; Ulaşlı MA; Erkeç S; Aktaş B; Yüksel O; Koçak E; Erdem HR
    Digestion; 2012; 86(2):86-93. PubMed ID: 22846190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
    Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
    Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands.
    Flik CE; Laan W; Smout AJ; Weusten BL; de Wit NJ
    BMC Gastroenterol; 2015 Nov; 15():168. PubMed ID: 26612205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
    Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
    Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
    Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden.
    Heidelbaugh JJ; Stelwagon M; Miller SA; Shea EP; Chey WD
    Am J Gastroenterol; 2015 Apr; 110(4):580-7. PubMed ID: 25781368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population.
    Guerin A; Carson RT; Lewis B; Yin D; Kaminsky M; Wu E
    J Med Econ; 2014 Aug; 17(8):577-86. PubMed ID: 24811855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
    Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
    Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.